Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Nov;26(5):611–642. doi: 10.1128/aac.26.5.611

Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys.

L H Schmidt, R N Rossan
PMCID: PMC179984  PMID: 6393864

Abstract

The studies summarized in this report were concerned with the capacities of repository preparations of cycloguanil pamoate (CGT-P) to protect rhesus monkeys against infections with drug-susceptible and pyrimethamine-resistant strains of Plasmodium cynomolgi. Administered intramuscularly as a suspension in an oleaginous vehicle, CGT-P (i) provided long-term protection against single and repetitive challenges of rhesus monkeys with sporozoites of the drug-susceptible B and Ro strains, (ii) effected prompt clearance of parasitemia in established infections, and (iii) delayed relapse. Protection was equated to absence of parasites on thick blood films, negative results when blood was transferred to susceptible recipients, and inability to activate infection by splenectomy. Eventual loss of protection was not related to emergence of parasites resistant to cycloguanil (CGT). Although protection varied from monkey to monkey, its mean duration was related directly to size of CGT-P dose and size of particles in the suspension. Urinary excretion studies indicated that protection persisted as long as the daily output of CGT did not fall below that attained with the parenterally administered hydrochloride salt at a dose equivalent to 0.015 mg of CGT per kg. Studies on infections with the resistant Ro/PM strain showed that the activity of CGT-P was compromised severely by resistance to pyrimethamine. Attempts to minimize this liability by concomitant administration of 4,4'-diacetyldiaminodiphenylsulfone met with limited success. These results suggest that even the best of the repository preparations of CGT-P, with or without 4,4'-diacetyldiaminodiphenylsulfone, would be useful only in areas where Plasmodium falciparum and Plasmodium vivax are fully susceptible to chlorguanide and pyrimethamine.

Full text

PDF
611

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black R. H., Dew B. B., Hennessy W. B., McMillan B., Torpy D. C. Studies on depot antimalarials. I. The effect of a single injection of the depot antimalarial CI-501 ("Camolar") on relapsing vivax malaria acquired in New Guinea. Med J Aust. 1966 Sep 24;2(13):588–592. [PubMed] [Google Scholar]
  2. Black R. H., Hennessy W. B., McMillan B., Dew B. B., Biggs J. C. Studies on depot antimalarials. 2. The effect of a single injection of the depot antimalarial CI-564 on relapsing vivax malaria acquired in New Guinea. Med J Aust. 1966 Oct 22;2(17):808–811. [PubMed] [Google Scholar]
  3. Bruce-Chwatt L. J. Chemoprophylaxis of malaria in Africa: the spent "magic bullet". Br Med J (Clin Res Ed) 1982 Sep 11;285(6343):674–676. doi: 10.1136/bmj.285.6343.674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CARRINGTON H. C., CROWTHER A. F., DAVEY D. G., LEVI A. A., ROSE F. L. A metabolite of paludrine with high antimalarial activity. Nature. 1951 Dec 22;168(4288):1080–1080. doi: 10.1038/1681080a0. [DOI] [PubMed] [Google Scholar]
  5. COATNEY G. R., CONTACOS P. G., LUNN J. S. FURTHER OBSERVATIONS ON THE ANTIMALARIAL ACTIVITY OF CI-501 (CAMOLAR) AGAINST THE CHESSON STRAIN OF VIVAX MALARIA. Am J Trop Med Hyg. 1964 May;13:383–385. doi: 10.4269/ajtmh.1964.13.383. [DOI] [PubMed] [Google Scholar]
  6. COATNEY G. R., CONTACOS P. G., LUNN J. S., KILPATRICK J. W., ELDER H. A. THE EFFECT OF A REPOSITORY PREPARATION OF THE DIHYDROTRIAZINE METABOLITE OF CHLORGUANIDE, CI-501, AGAINST THE CHESSON STRAIN OF PLASMODIUM VIVAX IN MAN. Am J Trop Med Hyg. 1963 Jul;12:504–508. doi: 10.4269/ajtmh.1963.12.504. [DOI] [PubMed] [Google Scholar]
  7. COATNEY G. R., COOPER W. C., YOUNG M. D. Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. J Natl Malar Soc. 1950 Dec;9(4):381–396. [PubMed] [Google Scholar]
  8. CONTACOS P. G., COATNEY G. R., LUNN J. S., KILPATRICK J. W. THE ANTIMALARIAL ACTIVITY OF CI-501 (CAMOLAR) AGAINST FALCIPARUM MALARIA. Am J Trop Med Hyg. 1964 May;13:386–390. doi: 10.4269/ajtmh.1964.13.386. [DOI] [PubMed] [Google Scholar]
  9. Chin W., Coatney G. R., King H. K. An evaluation of CI-564 against blood-induced chlorguanide-sensitive and chlorguanide-resistant strains of vivax malaria. Am J Trop Med Hyg. 1967 Jan;16(1):13–14. doi: 10.4269/ajtmh.1967.16.13. [DOI] [PubMed] [Google Scholar]
  10. Chin W., Contacos P. G., Coatney G. R., Jeter M. H., Alpert E. Evaluation of CI-564, A 1:1 mixture of cycloguanil pamoate (CI-501) and 4,4'-diacetylaminodiphenylsulfone (CI-556), against multiresistant falciparum malarias. Am J Trop Med Hyg. 1967 Sep;16(5):580–584. doi: 10.4269/ajtmh.1967.16.580. [DOI] [PubMed] [Google Scholar]
  11. Chin W., Lunn J. S., Buxbaum J., Contacos P. G. The effect of cycloguanil pamoate (CI-501) against a chlorguanide-resistant Chesson strain of Plasmodium vivax. Am J Trop Med Hyg. 1965 Nov;14(6):922–924. doi: 10.4269/ajtmh.1965.14.922. [DOI] [PubMed] [Google Scholar]
  12. Clyde D. F. Field trials of repository antimalarial compounds. J Trop Med Hyg. 1969 Apr;72(4):81–85. [PubMed] [Google Scholar]
  13. Contacos P. G., Coatney G. R., Lunn J. S., Chin W. Resistance to cycloguanil pamoate (CI-501) by falciparum malaria in West Pakistan. Am J Trop Med Hyg. 1965 Nov;14(6):925–926. doi: 10.4269/ajtmh.1965.14.925. [DOI] [PubMed] [Google Scholar]
  14. Contacos P. G., Coatney G. R., Lunn J. S., Chin W. The urinary excretion and the antimalarial activity of CI-501 (cycloguanil-pamoate, Camolar) against vivax and falciparum malaria. Am J Trop Med Hyg. 1966 May;15(3):281–286. doi: 10.4269/ajtmh.1966.15.281. [DOI] [PubMed] [Google Scholar]
  15. Elslager E. F. Progress in malaria chemotherapy. 1. Repository antimalarial drugs. Prog Drug Res. 1969;13:170–216. doi: 10.1007/978-3-0348-7068-9_4. [DOI] [PubMed] [Google Scholar]
  16. Fasan P. O. Field trial of cycloguanil pamoate in the treatment and suppression of malaria in Nigerian school children: a preliminary report. Trans R Soc Trop Med Hyg. 1970;64(6):839–849. doi: 10.1016/0035-9203(70)90103-3. [DOI] [PubMed] [Google Scholar]
  17. Gusmão H. H., Juarez E. A trial of CI-564 (dapolar), a repository antimalarial for prophylaxis in Amapá, Brazil. Am J Trop Med Hyg. 1970 May;19(3):394–400. doi: 10.4269/ajtmh.1970.19.394. [DOI] [PubMed] [Google Scholar]
  18. Harwin R. M. A field trial of the effectiveness of cycloguanil pamoate in Rhodesia. Cent Afr J Med. 1973 Jan;19(1):9–12. [PubMed] [Google Scholar]
  19. Howells R. E., Judge B. M. Sustained-release implants in the chemotherapy of experimental rodent malaria I. A comparison of the effects of some antimalarials in polydimethylsiloxane matrices. Ann Trop Med Parasitol. 1981 Oct;75(5):495–510. doi: 10.1080/00034983.1981.11687474. [DOI] [PubMed] [Google Scholar]
  20. Judge B. M., Howells R. E., Graham N. B., McNeill M. E. Sustained-release implants in the chemotherapy of experimental rodent malaria II. The effects of sulphadiazine, pyrimethamine and cycloguanil in biodegradable polymer matrices. Ann Trop Med Parasitol. 1981 Oct;75(5):511–519. doi: 10.1080/00034983.1981.11687475. [DOI] [PubMed] [Google Scholar]
  21. LUNN J. S., CHIN W., CONTACOS P. G., COATNEY G. R. CYCLOGUANIL PAMOATE (CI-501) AS A CAUSAL PROPHYLACTIC AGAINST A SOUTHERN RHODESIAN STRAIN OF FALCIPARUM MALARIA. Am J Trop Med Hyg. 1964 Nov;13:783–785. doi: 10.4269/ajtmh.1964.13.783. [DOI] [PubMed] [Google Scholar]
  22. Laing A. B., Pringle G., Lane F. C. A study among African school-children of the repository antimalarial properties of cycloguanil pamoate, 4,4+-diacetyldiaminodiphenylsulfone, and a combination of the two drugs. Am J Trop Med Hyg. 1966 Nov;15(6):838–848. doi: 10.4269/ajtmh.1966.15.838. [DOI] [PubMed] [Google Scholar]
  23. Laing A. B. The suppression of malaria with dapolar: a trial of 4-monthly doses in a village community in the Gambia, West Africa. Trans R Soc Trop Med Hyg. 1971;65(5):560–573. doi: 10.1016/0035-9203(71)90037-x. [DOI] [PubMed] [Google Scholar]
  24. McGregor I. A., Williams K., Walker G. H., Rahman A. K. Cycloguanil pamoate in the treatment and suppression of malaria in the Gambia, West Africa. Br Med J. 1966 Mar 19;1(5489):695–701. doi: 10.1136/bmj.1.5489.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Michel R., Pene P., Courtney K. O. Tolérance du Plasmodium falciparum a la pyriméthamine, au Proguanil et au CI.501 dans la région des Niayes (Sénégal) Bull Soc Pathol Exot Filiales. 1966 Sep-Oct;59(5):797–803. [PubMed] [Google Scholar]
  26. POWELL R. D., BREWER G. J., DEGOWIN R. L., ALVING A. S. STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM VIET-NAM. Bull World Health Organ. 1964;31:379–392. [PMC free article] [PubMed] [Google Scholar]
  27. Payet M., Pène P., Michel R., Sankalé M., Bernou J. C., Gueye I. Etude sur l'activité antimalarique du pamoate de dihydrotrizine C. I. Camolar. Bull Soc Pathol Exot Filiales. 1968;61(3):392–413. [PubMed] [Google Scholar]
  28. Payet M., Pène P., Michel R., Sankalé M., Bernou J. C., Guèye I. Etude sur l'activité antimalarique du Pamoate de dihydrotriazine C. I. Camolar. Bull Soc Med Afr Noire Lang Fr. 1966;11(2):147–169. [PubMed] [Google Scholar]
  29. Powell R. D., DeGowin R. L., Eppes R. B. Studies on the antimalarial effects of cycloguanil pamoate (CI-501) in man. Am J Trop Med Hyg. 1965 Nov;14(6):913–921. doi: 10.4269/ajtmh.1965.14.913. [DOI] [PubMed] [Google Scholar]
  30. Pène P., Michel R., Bernou J. C., Gueye Etude sur l'activité antimalarique du pamoate de dihydrotrizine (Camolar) en association à Camoquin. Bull Soc Pathol Exot Filiales. 1968;61(3):413–424. [PubMed] [Google Scholar]
  31. ROLLO I. M. The mode of action of sulphonamides, proguanil and pyrimethamine on Plasmodium gallinaceum. Br J Pharmacol Chemother. 1955 Jun;10(2):208–214. doi: 10.1111/j.1476-5381.1955.tb00084.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rieckmann K. H. A field study on the effects of a combination of cycloguanil pamoate and amodiquine against malaria in the Rabaul area of New Guinea. Am J Trop Med Hyg. 1966 Nov;15(6):833–837. doi: 10.4269/ajtmh.1966.15.833. [DOI] [PubMed] [Google Scholar]
  33. Rieckmann K. H. A new repository antimalarial agent, CI-564, used in a field trial in New Guinea. Trans R Soc Trop Med Hyg. 1967;61(2):189–198. doi: 10.1016/0035-9203(67)90156-3. [DOI] [PubMed] [Google Scholar]
  34. SCHMIDT L. H., LOO T. L., FRADKIN R., HUGHES H. B. Antimalarial activities of triazine metabolites of chlorguanide and dichlorguanide. Proc Soc Exp Biol Med. 1952 Jun;80(2):367–370. doi: 10.3181/00379727-80-19625. [DOI] [PubMed] [Google Scholar]
  35. SCHMIDT L. H., ROSSAN R. N., FISHER K. F. THE ACTIVITY OF A REPOSITORY FORM OF 4,6-DIAMINO-1(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE AGAINST INFECTIONS WITH PLASMODIUM CYNOMOLGI. Am J Trop Med Hyg. 1963 Jul;12:494–503. doi: 10.4269/ajtmh.1963.12.494. [DOI] [PubMed] [Google Scholar]
  36. Schmidt L. H. Appraisals of compounds of diverse chemical classes for capacities to cure infections with sporozoites of Plasmodium cynomolgi. Am J Trop Med Hyg. 1983 Mar;32(2):231–257. doi: 10.4269/ajtmh.1983.32.231. [DOI] [PubMed] [Google Scholar]
  37. Schmidt L. H., Harrison J., Rossan R. N., Vaughan D., Crosby R. Quantitative aspects of pyrimethamine-sulfonamide synergism. Am J Trop Med Hyg. 1977 Sep;26(5 Pt 1):837–849. doi: 10.4269/ajtmh.1977.26.837. [DOI] [PubMed] [Google Scholar]
  38. Schmidt L. H. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). I. The courses of untreated infections. Am J Trop Med Hyg. 1978 Jul;27(4):671–702. doi: 10.4269/ajtmh.1978.27.671. [DOI] [PubMed] [Google Scholar]
  39. Schmidt L. H. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). III. Methods employed in the search for new blood schizonticidal drugs. Am J Trop Med Hyg. 1978 Jul;27(4):718–737. doi: 10.4269/ajtmh.1978.27.718. [DOI] [PubMed] [Google Scholar]
  40. Schmidt L. H. Relationships between chemical structures of 8-aminoquinolines and their capacities for radical cure of infections with Plasmodium cynomolgi in rhesus monkeys. Antimicrob Agents Chemother. 1983 Nov;24(5):615–652. doi: 10.1128/aac.24.5.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Schmidt L. H. Studies on the 2,4-diamino-6-substituted quinazolines. III. The capacity of sulfadiazine to enhance the activities of WR-158,122 and WR-159,412 against infections with various drug-susceptible and drug-resistant strains of Plasmodium falciparum and Plasmodium vivax in owl monkeys. Am J Trop Med Hyg. 1979 Sep;28(5):808–818. [PubMed] [Google Scholar]
  42. THOMPSON P. E., OLSZEWSKI B. J., ELSLAGER E. F., WORTH D. F. LABORATORY STUDIES ON 4,6DIAMINO-1-(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE PAMOATE (CI-501) AS A REPOSITORY ANTIMALARIAL DRUG. Am J Trop Med Hyg. 1963 Jul;12:481–493. doi: 10.4269/ajtmh.1963.12.481. [DOI] [PubMed] [Google Scholar]
  43. THOMPSON P. E., OLSZEWSKI B., WAITZ J. A. LABORATORY STUDIES ON THE REPOSITORY ANTIMALARIAL ACTIVITY OF 4,4'-DIACETYLAMINODIPHENYLSULFONE, ALONE AND MIXED WITH CYCLOGUANIL PAMOATE (CI-501). Am J Trop Med Hyg. 1965 May;14:343–353. doi: 10.4269/ajtmh.1965.14.343. [DOI] [PubMed] [Google Scholar]
  44. Wise D. L., Gresser J. D., McCormick G. J. Sustained release of a dual antimalarial system. J Pharm Pharmacol. 1979 Apr;31(4):201–204. doi: 10.1111/j.2042-7158.1979.tb13478.x. [DOI] [PubMed] [Google Scholar]
  45. Wise D. L., McCormick G. J., Willet G. P., Anderson L. C., Howes J. F. Sustained release of sulphadiazine. J Pharm Pharmacol. 1978 Nov;30(11):686–689. doi: 10.1111/j.2042-7158.1978.tb13365.x. [DOI] [PubMed] [Google Scholar]
  46. Wise D. L., McCormick G. J., Willet G. P., Anderson L. C. Sustained release of an antimalarial drug using a copolymer of glycolic/lactic acid. Life Sci. 1976 Sep 15;19(6):867–873. doi: 10.1016/0024-3205(76)90314-3. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES